Pertuzumab Mechanism of Action. New Hope – Old target

Scientists and researchers have their odd ways of solving problems, and when they team up with one of the biggest biotech companies, their ideas can go beyond research papers—and become real-world solutions we get to see. Brief History of Pertuzumab Pertuzumab (Parjeta) is a clear example of a scientific and marketing genius. It entered the … Read more

6 Major Targets for the Medications

Angiotensin receptor and blocker

Have you ever wondered exactly how the medications you take actually work? It’s not magic; it’s molecular biology. Every drug, from a simple over-the-counter painkiller to cutting-edge chemotherapy, must interact with a specific component in your body to produce its therapeutic effect. In pharma science, those biological or chemical structures of your body targeted by … Read more

Bimzelx Mechanism of Action. New mAb to Clear IL-17

Bimzelx, bemakizumab mechanism of action

Bimzelx (Bimekizumab) is a monoclonal antibody, which calms down inflammation in psoriasis and psoriatic arthritis by binding and blocking two pro-inflammatory molecules: Filling two needs with one dead, scientists developed an antibody against a site common for both A and F subtypes of interleukin 17. It allowed bimekizumab to completely shoutdown this signalling molecule from … Read more

Teclistamab Mechanism of Action. Twice more Powerful

I am Taclistamab, designed in the lab,A mighty bi-specific mAb.One end binds cancer, holding it tight,One end finds T-cells to join the fight.I help the immune system take its aim,And snipe myeloma, ending its game. How Taclistamab helps Immune System to fight Myeloma Teclistamab is a new approach of cancer treatment. It has two targets: … Read more